geraniol has been researched along with Lung Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fatima, K; Luqman, S; Meena, A; Wani, ZA | 1 |
| Crespo, R; de Bravo, MG; Galle, M; Kladniew, BR; Polo, M; Villegas, SM | 1 |
2 other study(ies) available for geraniol and Lung Neoplasms
| Article | Year |
|---|---|
Geraniol exerts its antiproliferative action by modulating molecular targets in lung and skin carcinoma cells.
Topics: A549 Cells; Acyclic Monoterpenes; Carcinoma; Cell Line, Tumor; Humans; Lung Neoplasms; Molecular Docking Simulation; Skin Neoplasms | 2021 |
Suppression by geraniol of the growth of A549 human lung adenocarcinoma cells and inhibition of the mevalonate pathway in culture and in vivo: potential use in cancer chemotherapy.
Topics: Acyclic Monoterpenes; Adenocarcinoma; Adenocarcinoma of Lung; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cholesterol; Female; Humans; Hydroxymethylglutaryl CoA Reductases; Lung Neoplasms; Mevalonic Acid; Mice; Mice, Nude; Terpenes; Xenograft Model Antitumor Assays | 2014 |